Loading clinical trials...
Loading clinical trials...
SCARFREE-001: A Phase 2 Dose-Finding and Proof-of-Concept Study of Intradermal Verteporfin for Scar Prevention in Open and Closed Surgical Wounds
Conditions
Interventions
Verteporfin Injection
Saline injection
Locations
1
Denmark
Odense University Hospital
Odense, Denmark
Start Date
June 1, 2026
Primary Completion Date
February 1, 2028
Completion Date
February 1, 2028
Last Updated
March 23, 2026
NCT07359352
NCT03467724
NCT01789346
NCT02397564
NCT01689857
Lead Sponsor
Odense University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions